Genpact Limited (NYSE:G - Get Free Report)'s stock price gapped up prior to trading on Friday following a dividend announcement from the company. The stock had previously closed at $49.40, but opened at $54.93. Genpact shares last traded at $55.20, with a volume of 750,294 shares changing hands.
The newly announced dividend which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.25%. Genpact's payout ratio is 21.48%.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on the company. Needham & Company LLC upped their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday. Robert W. Baird upped their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a report on Friday, November 8th. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and raised their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $60.00 in a report on Friday. Six analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $48.44.
View Our Latest Stock Analysis on Genpact
Genpact Stock Performance
The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The stock's 50-day moving average is $45.09 and its 200 day moving average is $41.41. The stock has a market cap of $9.62 billion, a price-to-earnings ratio of 19.23, a P/E/G ratio of 1.63 and a beta of 1.20.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.61%. As a group, analysts predict that Genpact Limited will post 3.08 earnings per share for the current fiscal year.
Insider Buying and Selling at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 9,000 shares of the business's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the sale, the chief executive officer now owns 267,404 shares of the company's stock, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 35,058 shares of company stock worth $1,558,675. Insiders own 2.80% of the company's stock.
Institutional Investors Weigh In On Genpact
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Sanctuary Advisors LLC bought a new stake in Genpact in the 2nd quarter valued at about $335,000. Inspire Investing LLC lifted its position in Genpact by 242.0% in the third quarter. Inspire Investing LLC now owns 37,277 shares of the business services provider's stock worth $1,462,000 after purchasing an additional 26,376 shares during the period. Creative Planning lifted its holdings in shares of Genpact by 19.4% in the third quarter. Creative Planning now owns 30,590 shares of the business services provider's stock valued at $1,199,000 after buying an additional 4,976 shares during the period. Birch Capital Management LLC boosted its position in shares of Genpact by 23.6% during the 3rd quarter. Birch Capital Management LLC now owns 93,216 shares of the business services provider's stock valued at $3,655,000 after purchasing an additional 17,827 shares in the last quarter. Finally, Aaron Wealth Advisors LLC bought a new position in shares of Genpact in the third quarter valued at $270,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.
Genpact Company Profile
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.